Spruce Biosciences, Inc. · NASDAQ:SPRB

Orbimed Advisors LLC reported a 5.60% stake in Spruce Biosciences, Inc. (Schedule 13G/A)

Event Sep 30, 2026 · Filed Nov 16, 2026

Orbimed Advisors LLC reported a 5.60% stake in Spruce Biosciences, Inc., 162,000 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).

Stake
5.60%
Shares
162,000
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
OrbiMed Advisors LLC5.60%162,000
OrbiMed Genesis GP LLC5.60%162,000
OrbiMed Capital LLC2.80%80,800

Source

Download original · View original at SEC

Related